- Home
- INFY vs BDX Comparison
INFY vs BDX Comparison
Compare INFY & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INFY | BDX |
|---|---|---|
| Founded | 1981 | 1897 |
| Country | India | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.4B | 40.3B |
| IPO Year | 1999 | 1997 |
Fundamental Metrics
Financial Performance| Metric | INFY | BDX |
|---|---|---|
| Price | $10.95 | $147.62 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 13 |
| Target Price | $14.60 | ★ $186.00 |
| AVG Volume (30 Days) | ★ 19.5M | 2.4M |
| Earning Date | 04-23-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.56% | 2.89% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.25 |
| Revenue | N/A | ★ $21,840,000,000.00 |
| Revenue This Year | $2.87 | N/A |
| Revenue Next Year | $6.67 | $3.02 |
| P/E Ratio | ★ $19.11 | $575.68 |
| Revenue Growth | N/A | ★ 8.24 |
| 52 Week Low | $10.46 | $140.11 |
| 52 Week High | $30.00 | $213.08 |
Technical Indicators
Market Signals| Indicator | INFY | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 35.82 | 51.27 |
| Support Level | N/A | $142.48 |
| Resistance Level | $13.42 | $153.09 |
| Average True Range (ATR) | 0.38 | 3.42 |
| MACD | -0.13 | -0.10 |
| Stochastic Oscillator | 17.95 | 54.91 |
Price Performance
Historical ComparisonAbout INFY Infosys Limited
Infosys is an IT services provider based in Bengaluru, India, with offices in more than 50 countries. The company leverages its offshore outsourcing model to serve clients across different industries, such as financial services and manufacturing. Infosys' IT services offerings include consulting, digital transformation, and business process outsourcing.
About BDX Becton Dickinson and Company
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.